CRNX is Crinetics Pharmaceuticals, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $84.95. Market cap: $9.01B. Capital Quality Rank: 71/100 — Efficient operator.
Stock snapshot
| Price | $84.95 |
| Market cap | $9.01B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 71 / 100 · Efficient operator |
| ROIC (TTM) | -45.8% |
| Revenue CAGR (3y) | 17.6% |
| Shareholder buyback yield | -14.11% |
| Altman Z-score zone | Safe |
About CRNX
Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.
Related non-dividend companies
Other non-dividend stocks investors research alongside CRNX. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is CRNX's current stock price?
CRNX (Crinetics Pharmaceuticals, Inc.) is currently trading at $84.95.
Does CRNX pay a dividend?
CRNX (Crinetics Pharmaceuticals, Inc.) does not currently pay a regular dividend.
What is CRNX's Capital Quality Rank?
CRNX has a Capital Quality Rank of 71/100 — Efficient operator. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track CRNX in DiviDrip
Add CRNX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search CRNX and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-02. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.
